Phase 1 Study of L-NMMA in Patients With Liver Cirrhosis
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase 1 study of the effects of nitric oxide inhibition with L-NMMA in patients with liver
cirrhosis and healthy controls. It is hypothesized that nitric oxide availability is
increased in liver cirrhosis.